James P. Shaffer's most recent trade in Eiger BioPharmaceuticals Inc was a trade of 71,250 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 12, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Eiger BioPharmaceuticals Inc | James P. Shaffer | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 71,250 | 71,250 | - | - | Stock Option (Right to Buy) | |
Eiger BioPharmaceuticals Inc | James P. Shaffer | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 11,875 | 29,296 (0%) | 0% | 0 | Common Stock |